momelotinib

M3O1M3E1L1O1T1I1N1I1B3

noun

A medication belonging to the class of Janus kinase inhibitors, being developed as a drug to treat myelofibrosis.

Scrabble 17

Meanings

nounmomelotinib (uncountable)
  1. uncountablemedicineA medication belonging to the class of Janus kinase inhibitors, being developed as a drug to treat myelofibrosis.

    Momelotinib is a JAK1/JAK2 inhibitor as well as an activin receptor–like kinase (ALK1) inhibitor. Because ALK1 is a receptor for bone morphogenic proteins, momelotinib is undergoing testing for the treatment of myelofibrosis (78).

    2021 December, Christine Liu, Jacqueline Kieltyka, Roy Fleischmann, Massimo Gadina, John J. O’Shea, “A Decade of JAK Inhibitors: What Have We Learned and What May Be the Future?”, in Arthritis & Rheumatology, volume 73, number 12, →DOI, page 2173
Cite this entry
APA

momelotinib. (n.d.). In WatkinsX Dictionary. Retrieved November 4, 2026, from https://dictionary.watkinsx.com/word/momelotinib

MLA

“momelotinib.” WatkinsX Dictionary, https://dictionary.watkinsx.com/word/momelotinib. Accessed November 4, 2026.

Chicago

WatkinsX Dictionary, s.v. “momelotinib,” accessed November 4, 2026, https://dictionary.watkinsx.com/word/momelotinib.

Source: momelotinib on Wiktionary, CC BY-SA 4.0.